Lymphoid Malignancies


Price: £ 49.99
Including taxes

Quantity :

  • A highly illustrated guide and reference for haematologists, oncologists and clinical scientists
  • Guiding investigation, differential diagnosis, prognosis and treatment options
  • Evidence-based Handbook - placing the wisdom of leading clinicians in the service of best practice in patient care

Meeting the needs of haematologists, haematopathologists, oncologists and clinical scientists for an up-to-date reference, this atlas provides a visual presentation of lymphoproliferative disorders, lymphoid leukaemias and plasma cell neoplasms. Each malignancy is surveyed based on molecular and cellular changes, including histochemistry, cytochemistry and relevant radiographs. Pertinent clinical information relating to clinical presentation, differential diagnosis and prognostic indicators are concisely outlined, using numerous graphics and citing key references in the field.

 

CONTENTS: The molecular basis of lymphoma, acute lymphoblastic leukaemia, chronic lymphocytic leukaemia/small lymphocytic lymphoma and monoclonal B-cell lymphocytosis, B-cell prolymphocytic leukaemia, follicular lymphoma, mantle cell lymphoma, lymphoplasmacytic lymphoma, nodal marginal zone lymphoma, extranodal marginal zone lymphoma of MALT type, splenic marginal zone lymphoma, hairy cell leukaemia, splenic B-cell lymphoma/ leukaemia, unclassifiable: hairy cell leukaemia variant and splenic diffuse red pulp small B-cell lymphoma, Burkitt lymphoma, diffuse large B-cell lymphoma, high-grade B-cell lymphomas, AIDS-related and other immunodeficiency-related lymphomas, adult T-cell leukaemia/lymphoma, mycosis fungoides, Sézary syndrome and other cutaneous T-cell lymphomas, T-cell large granular lymphocytic leukaemia and chronic lymphoproliferative disorder of NK cells, aggressive NK-cell leukaemia, T-cell prolymphocytic leukaemia, T follicular helper cell lymphomas, anaplastic T-cell lymphoma, other T-cell lymphomas, multiple myeloma (plasma cell myeloma), monoclonal gammopathy of undetermined significance (MGUS), other plasma cell neoplasms, Hodgkin lymphoma